Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Inclusion Criteria:

• Patient over the age of 18;
• Diagnostic COVID-19 by RT-PCR;
• Hospitalisation in resuscitation for the management of complications related to COVID-19
• Implanted ECMO-VV during hospitalisation;
• Patient agreeing to participate in the study

Exclusion Criteria:

• Sujet under guardianship or trusteeship
• Sujet under safeguard of justice